exRNAdisease

Entry Detail

---



General Information

Database ID: exR0354693 RNA Name: hsa-miR-520b-3p RNA Type: miRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 53701267 End Site(bp): 53701287 External Links: hsa-miR-520b-3p

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE93850 Description: Serum miRNAs in Patients with Glioblastoma Multiforme Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 22 Number of Control: 8 Number of Samples: 30

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand TNS1 chr2 217799588 218033982 - CLCN6 chr1 11806096 11848079 + SIRPA chr20 1894167 1940592 + CELF2 chr10 10798397 11336675 + MBP chr18 76978827 77133683 - PLAGL2 chr20 32192504 32207743 - APP chr21 25880550 26171128 - KLHL28 chr14 44924319 45042322 - SEC16A chr9 136440096 136483759 - CCDC93 chr2 117915478 118014133 - MAGI3 chr1 113390515 113685923 + PTP4A1 chr6 63521746 63583436 + SYAP1 chrX 16719612 16765340 + SEMA3C chr7 80742538 80922359 - ADAR chr1 154582057 154628013 - CUL1 chr7 148697914 148801110 + CHD9 chr16 53055033 53329150 + TRIB1 chr8 125430358 125438403 + SLC16A14 chr2 230034982 230068993 - IFNAR1 chr21 33324429 33359864 + WDR82 chr3 52254434 52288020 - RUNDC1 chr17 42980565 42993690 + NPAS2 chr2 100820139 100996829 + JPT1 chr17 75135248 75168281 - LONP2 chr16 48244300 48363122 + OCRL chrX 129539849 129592561 + ZFAND4 chr10 45615500 45672780 - PHC3 chr3 170086732 170181749 - ATXN1 chr6 16299112 16761491 - FAM177A1 chr14 35044907 35113130 + miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AL049840.4 chr14 103694516 103695050 - ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - FGD5-AS1 chr3 14920347 14948424 - MIR17HG chr13 91347820 91354579 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE93850 Sample Source: Blood Source Fraction: Serum Platform: GPL22948 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1032 Sample treatment protocol: NA RNA Extract protocol: Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) RNA library preparation protocol: 0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.

Reference

PMID: 28931080 Title: Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma Author: Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX Journal: PLoS One. 2017 Sep 20;12(9):e0184969. Description: we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.